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8 Abstract
9 Objective We tested the effect of various doses of bacterial
10 lipopolysaccharide (LPS, endotoxin) on the expression of
11 CD63 and the in vitro release of histamine by basophils
12 stimulated with ragweed allergen in patients with or without
13 ragweed and mite allergies.
14 Methods The peripheral blood of 11 patients with ragweed
15 allergy, 10 patients with mite allergy and 14 control patients
16 was incubated with ragweed allergen extract following
17 pretreatment with varying doses of LPS. The expression of
18 CD63 in basophils was measured by ﬂow cytometry, and the
19 release of histamine was determined by ELISA.
20 Results In the samples of patients with ragweed allergy
21 that were exposed to speciﬁc allergen, only high doses of
22 LPS signiﬁcantly elevated the expression of CD63
23 (200 ng/ml; 1,000 EU/ml) and the release of histamine
24 (2,000 ng/ml; 10,000 EU/ml). There was no effect of LPS
25 in any other cases.
26 Conclusions Bacterial LPS (endotoxin) concentrations
27 higher than 200 ng/ml (1,000 EU/ml), which rarely occurs
28 in nature, could only activate the basophils from atopic
29 patients whilst in the presence of the speciﬁc allergen.
30Thus, the restoration of the urban, ‘‘microbe-poor’’ milieu
31with endotoxin (as LPS) can be a promising and harmless
32approach for allergy prevention.
33
34Keywords Bacterial lipopolysaccharide (endotoxin) 
35CD63  Histamine  Atopic allergy
36
37Introduction
38Bacterial lipopolysaccharide (LPS, ‘‘endotoxin’’), a cell wall
39component ofGram-negative bacteria, represents a prominent
40pathogen-associated molecular pattern that is recognised by
41the innate immune system through members of the highly
42conserved family of Toll-like receptors [1], and it is an ubiq-
43uitous and natural component of the external and internal
44milieu. In the last decade, the biological and ecological sig-
45niﬁcance ofLPShas increased fromstudies showing its ability
46to protect fromandprevent allergy [2–6].Conversely, it is also
47known that acute inhalation of high concentrations of endo-
48toxin can cause wheezing and coughing in the ﬁrst year of life
49[7], and can aggravate already existing inﬂammation in
50asthmatics [8]. It has also been observed that bacterial endo-
51toxin could potentiate the release of histamine from basophils
52in the presence of a speciﬁc allergen [9] and anti-IgE, in
53addition to potentiating the non-immunological histamine
54release (HR) [10]. However, the amount of bacterial LPS that
55can be tolerated in the environment or in the blood of atopic
56and non-atopic patients without causing harmful activation of
57circulating basophils remains uncertain. For example, in 229
58inner-city school dust samples and in 118 bedroom dust
59samples tested inBoston, themedian endotoxin concentration
60was 13.4 EU/mg (range 0.7–360.7 EU/mg) [11].
61In industrialised nations and high-income regions of the
62world, the decline of infectious diseases is paralleled by an
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63 increase in allergic, autoimmune and chronic inﬂammatory
64 diseases. The changes in lifestyle that individually and
65 collectively impact the intestinal microbiota may, at least
66 in part, account for the pandemic character of these diseases
67 [13]. Therefore, the concept of artiﬁcial restoration of the
68 urban milieu with endotoxin or other microbiological
69 derivatives has become prominent [14].
70 Beyond the classical HR assay, new ﬂow cytometric
71 methods are emerging to assess the activation of basophils
72 [15, 16]. Amongst several other markers, CD63 and
73 CD203c have most commonly been applied in basophil
74 activation assays [17]. The CD63 antigen, lysosome-asso-
75 ciated membrane protein (LAMP-3), is not readily
76 detectable on resting basophils but is upregulated rapidly
77 on the outer cell membrane following activation with
78 speciﬁc stimuli [18]. We chose to measure CD63 expres-
79 sion in this study, as this antigen was expressed with higher
80 density on IgE-activated basophils than the transiently
81 expressing CD203c antigen [17]. Furthermore, CD63
82 expression more closely reﬂects the anaphylactic degran-
83 ulation pathway that is associated with the release of
84 preformed mediators, compared to piecemeal degranula-
85 tion, which can be measured by other groups of activation
86 markers such as CD203c [19].
87 In the current study, we aimed to compare the in vitro
88 effects of various doses of bacterial LPS on the expression
89 of CD63 and the release of histamine in basophils, which
90 were derived from healthy subjects or atopic patients who
91 were sensitised either to ragweed or to mite allergen. The
92 assays were performed in the presence and absence of
93 soluble ragweed allergen.
94 Materials and methods
95 Subjects
96 Atopic donors suffering from moderate allergic rhinitis
97 with ragweed (w1)-, house dust mite Dermatophagoides
98 pteronyssinus (d1)- or D. farinae (d2)-speciﬁc IgE took
99 part in the study. Eleven of the patients (six males, ﬁve
100 females; mean age 13.0 ± 7.8 years, range 6–34) were
101 monosensitised to ragweed. They were investigated before
102 the pollen season, and they did not take any anti-histamine
103 drugs. Ten of the patients (six males, four females; mean
104 age 10.2 ± 3.61 years, range 5–17) were monosensitised
105 to house dust mite d1 or d2. Their anti-histamine treatment
106 was stopped at least 72 h before the experiments. None of
107 the atopic patients were treated with corticosteroids during
108 the study. Patients were excluded if they had speciﬁc IgE to
109 any inhalant allergens other than w1, d1 or d2. Fourteen
110 non-atopic healthy individuals (six males, eight females;
111 mean age 11.38 ± 7.9 years, range 6–33) were the
112controls. All patients, or their parents in the case of chil-
113dren, gave written informed consent.
114Treatment with LPS
115Heparinised whole blood (1 ml) was preincubated for
11615 min at 37
C with various amounts of Escherichia coli
117bacterial LPS (Serotype 0111:B4, Sigma-Aldrich, Stein-
118heim, Germany) that was diluted in sterile HEPES buffer to
119ﬁnal concentrations of 20, 200 or 2,000 ng/ml. LPS diluted
120to 0.2 ng/ml was equivalent to an endotoxin value of
1211 EU/ml. Ambrosie mix allergen extract (Lopharma,
122Milan, Italy) was used as ragweed allergen. 100 ll of the
123extract was diluted 1:50 with sterile HEPES buffer and
124added to the blood at 37
C for 45 min. The reaction was
125stopped by cooling the tubes on ice. Following centrifu-
126gation, the supernatants were collected and stored for
127histamine determination at -70
C. The pelleted cells were
128resuspended in cold sterile HEPES buffer containing 5 mM
129EDTA, and they were used for the CD63 expression assay
130of basophils.
131Analysis of CD63 expression in basophils by ﬂow
132cytometry
133The pelleted cells were labelled with anti-human IgE-FITC
134(goat) and monoclonal anti-human CD63-PE antibodies
135(Caltag, Burlingame, CA) at 4
C for 60 min. Basophils
136presenting highly ﬂuorescent IgE-FITC were gated (100 %
137reference). Amongst these cells, the percentage of CD63
138positive basophils was determined by the Becton–Dickin-
139son FACSCalibur ﬂow cytometer (BD Bioscience,
140Heidelberg, Germany) [12]. The CD63 percentage in rag-
141weed and/or LPS activated samples was corrected with the
142percentage obtained with buffer-treated samples. At least
143500–1,000 basophils were counted.
144The enhancement of ragweed-induced basophil CD63
145expression in the presence of LPS was calculated using the
146following equation:
Enhancement %ð Þ
¼
Mean% CD63ragweedþLPS Mean% CD63ragweed
Mean% CD63ragweed
 100
1489Measurement of histamine release
150Histamine levels in the culture supernatants were deter-
151mined by ELISA (Immunotech, Marseille, France). After
152lysing the cells with distilled water and repeated freezing
153and thawing, the total histamine contents were measured.
154The results were expressed as the percent of the total his-
155tamine content. The enhancement of ragweed-induced HR
156in the presence of LPS was calculated:
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Enhancement %ð Þ
¼
Mean% HRragweedþLPS Mean% HRragweed
Mean% HRragweed
 100
1589 Testing for IgE
160 Patients were tested for total serum IgE and ragweed- and
161 house-dust-mite-speciﬁc IgE (D. pteronyssinus, D. farinae)
162 by ELISA (Adaltis, Casalecchio di Reno, Italy). Some other
163 potential inhalative allergens were also tested, and samples
164 showing positive results for allergens other than ragweed-
165 or mite-speciﬁc IgE were excluded from the study.
166 Statistical analysis
167 A repeated measures ANOVA was used to analyse the
168 differences in the various experimental groups. Multiple
169 comparisons were performed using the post hoc Tukey test.
170 The results are presented as the mean ± standard error.
171 The Mann–Whitney test was performed to compare the
172 enhancement of basophil CD63 expression and the HR at a
173 given LPS concentration. P-values\0.05 were considered
174 signiﬁcant.
175 Results
176 The effect of LPS on CD63 expression of basophils
177 LPS administered in the range of 20–2,000 ng/ml dose-
178 dependently increased the expression of CD63 in basophils
179 from ragweed-sensitised patients in the presence of rag-
180 weed allergen (repeated measures ANOVA, P\ 0.001).
181 The lower dose of LPS (20 ng/ml, 100 EU/ml) caused a
182 slight, but insigniﬁcant, increase in CD63 expression
183 compared to the LPS-free milieu. Conversely, there were
184 signiﬁcant enhancements in CD63 expression following the
185 addition of 200 ng/ml (1,000 EU/ml) and 2,000 ng/ml
186 (10,000 EU/ml) of LPS compared to 20 ng/ml
187 (100 EU/ml) and LPS-free systems (post hoc Tukey’s test,
188 P\ 0.05 for both). In the patients with mite allergy and in
189 the non-atopic healthy individuals, the ragweed allergen
190 did not cause an increase in basophil CD63 expression
191 following preincubation with the three LPS concentrations.
192 Furthermore, LPS alone (without a speciﬁc allergen or IgE)
193 did not enhance the expression of CD63 in any patient
194 group at any concentration (Fig. 1).
195 Inﬂuence of LPS on the release of histamine
196 from basophils
197 The ability of various doses of LPS to enhance the release
198 of histamine in whole blood from ragweed-sensitised
199patients in the presence of ragweed allergen was investi-
200gated and found to result in a signiﬁcant change (repeated
201measures ANOVA, P\ 0.002). The analysis revealed that
202only the 2000 ng/ml (10,000 EU/ml) dose of LPS resulted
203in a signiﬁcant elevation of CD63 expression compared
204either to untreated cells or to the group treated with 20 ng/
205ml (100 EU/ml) of LPS, but only in those cells which were
206stimulated by the speciﬁc ragweed allergen (post hoc
207Tukey’s test, P\ 0.05). In the patients with mite allergy
208and in the non-atopic healthy individuals, the ragweed
209allergen did not induce HR from the basophils either with
210or without LPS (Fig. 2).
211Comparison of the activating capacity of LPS
212on the expression of CD63 and the release of histamine
213in basophils activated by speciﬁc allergen
214As shown in Fig. 3, much smaller doses of LPS were
215required to increase the expression of CD63 than the
216release of histamine in the basophils of atopic patients
Fig. 1 The effect of LPS on the basophil expression of CD63 in the
absence and presence of ragweed allergen in ragweed and mite
allergy patients and in non-atopic healthy controls. Heparinised whole
blood samples obtained from ragweed- or mite-sensitised atopic
donors and non-atopic healthy controls were preincubated with
various amounts of LPS for 15 min followed by incubation with rag-
weed allergen for 45 min at 37 C. After staining the cells with anti-
IgE-FITC and CD63-PE, basophil cells presenting highly ﬂuorescent
IgE-FITC were gated (100 % reference). Amongst these cells, the
percent of CD63 positive basophils was determined by ﬂow
cytometry. A repeated measures ANOVA test was carried out in all
groups that were treated with ragweed allergen, giving a result of
P\ 0.001. All pairwise multiple comparisons were performed by the
post hoc Tukey’s test, and the signiﬁcant P values are shown. The
results are expressed as the group mean ± SEM
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217 stimulated by their speciﬁc allergen in vitro. These ﬁndings
218 show that the increase in the CD63 expression is a more
219 sensitive marker of the activation of basophils than the
220 release of histamine. However, the release of histamine
221 indicates a functional activation of the basophils.
222 Discussion
223 Our present study provides experimental in vitro evidence
224 that, in the presence of a speciﬁc allergen and IgE, only
225 extremely high concentrations of bacterial LPS ([200
226 ng/ml, 1,000 EU/ml) can cause signiﬁcant increases in the
227 expression of CD63 in the basophils of atopic patients. To
228 induce a statistically signiﬁcant release of histamine in the
229 same system, however, a much higher (2,000 ng/ml,
230 10,000 EU/ml) dose of LPS was required. This difference
231 in the LPS doses shows that the elevated expression of
232 CD63 expression on the surface of basophils could be a
233 more sensitive, and potentially earlier, marker of basophil
234 activation than the release of histamine. It is the release of
235histamine, however, that may have more important clinical
236importance. In agreement with our results, other studies
237have shown that HR does not strictly correlate with baso-
238phil CD63 expression [20]. In the patients with mite allergy
239and in the healthy controls, neither ragweed allergen nor
240any dose of LPS (20–2,000 ng/ml, 100–10,000 EU/ml)
241could induce basophil activation. These results show that
242only unusually high (1,000, 2,000 EU/ml) amounts of LPS
243may increase the severity of an acute allergic reaction
244based on basophil activation (CD63 expression and HR).
245LPS alone is not effective in the cases where the allergen
246and its speciﬁc IgE are not present.
247Notably, Lopharma informed us that the ragweed allergen
248extract used in this study was not completely free of endo-
249toxin contamination. The amount of contamination was far
250below the 20 ng/ml used as the smallest LPS dose in the
251experiments and therefore was not activating the basophils.
252A great number of studies conﬁrm that endotoxin is a
253protective and preventive factor for asthma in older chil-
254dren, whereas it is a risk factor for wheezing in younger
255children. [21]. Although histamine may have a pathogenic
256role in non-speciﬁc coughing and wheezing [22, 23], our
257results indicate that the naturally existing concentrations of
258endotoxin in the environment (367 mg EU/mg, 100 U/m
3,
Fig. 2 The effect of LPS on the release of histamine from basophils
treated with ragweed allergen in patients with ragweed and mite
allergy and in non-atopic healthy controls. Heparinised whole blood
samples obtained from ragweed or mite sensitised atopic donors and
non-atopic healthy controls were preincubated with various amounts
of LPS for 15 min followed by incubation with ragweed allergen for
45 min at 37 C. The cells were pelleted, and the histamine content in
the supernatants was determined by ELISA. The histamine release
was calculated as the percent of the total histamine content.
A repeated measures ANOVA test was carried out in all groups
treated with ragweed allergen, giving a result of P = 0.002. Pairwise
multiple comparisons were performed by the post hoc Tukey’s test,
and the signiﬁcant P values are shown. The results are expressed as
the group mean ± SEM
Fig. 3 Comparison of the activating capacity of LPS on the
expression of CD63 and the release of histamine in basophils
activated by ragweed allergen in patients with ragweed allergy.
The enhancement of ragweed-induced basophil activation in the
presence of LPS was deﬁned as the following:
Enhancement %ð Þ ¼
Mean% activationragweedþLPSMean% activationragweed
Mean% activationragweed
 100B-
asophil activation was measured as basophil CD63 expression or
histamine release from basophils. The solid line and filled circle
represent the enhancement in CD63 expression, and the dotted line
and open circle represent the enhancement in histamine release. The
data are presented as the means, and the bars represent the SEM
(n = 11). The asterisks indicates a signiﬁcant (P\ 0.05) enhance-
ment of CD63 expression versus the enhancement of histamine
release at a given LPS concentration (Mann–Whitney test). LPS
lipopolysaccharide
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259 1,550 EU/m
3 [24–28] are insufﬁcient to induce enough HR
260 to provoke clinical symptoms. However, naturally occur-
261 ring endotoxin concentrations can trigger the release of
262 leukotrienes [29] and activate the complement system,
263 resulting in the production of bronchoconstrictor C3a and
264 C5a [30] in some patients. For example, the importance of
265 leukotrienes was recognised in the use of leukotriene D4 in
266 the bronchial provocation test [31]. We hypothesise that the
267 release of leukotrienes and activation of complement by
268 high doses of LPS could be a potential cause of non-speciﬁc
269 wheezing and coughing.
270 The restoration of the urban environment by using a
271 ‘‘tolerable’’ dose and form of bacterial LPS can be a
272 plausible new method of allergy prevention in the future
273 [14]. LPS taken from the environment may inﬂuence the
274 development and expansion of CD4
?Foxp3? regulatory
275 (immunosuppressive) T cells [32]. The airway respon-
276 siveness of a patient on endotoxin depends on the existence
277 of individual Toll-like receptor 4 variants [29]. According
278 to our present data, a naturally occurring high level of
279 endotoxin in the dust of a swine facility (1,550 EU/m
3) is
280 approximately 1,000-fold lower than the lowest concen-
281 tration of LPS required to activate basophils in atopic
282 patients (1,000 EU/ml). Thus, the artiﬁcial enrichment of
283 the environment with special types of endotoxin (having
284 Th1 stimulating effects without causing non-speciﬁc
285 wheezing and coughing) can be a realistic and harmless
286 new approach to allergy prevention in infants.
287 In conclusion, our results show that only unusually high
288 doses of bacterial LPS in the presence of speciﬁc allergen
289 can trigger the expression of CD63 and the release of
290 histamine in the basophils of atopic patients. Other acti-
291 vation processes of the blood may be involved in the
292 pathomechanism of non-speciﬁc coughing or wheezing
293 induced by high doses of LPS.
294 These data support the idea that restoration of the urban
295 environment with a tolerable dose and form of bacterial
296 LPS can serve to prevent allergy.
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